Infective endocarditis according to type 2 diabetes mellitus status: an observational study in Spain, 2001-2015.
Comorbidities
Heart valve surgery
In-hospital mortality
Infective endocarditis
Type 2 diabetes mellitus
Journal
Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637
Informations de publication
Date de publication:
21 11 2019
21 11 2019
Historique:
received:
23
08
2019
accepted:
12
11
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
19
5
2020
Statut:
epublish
Résumé
The main aims of this study were to describe trends and outcomes during admission for infective endocarditis (IE) in people ≥ 40 years old with or without type 2 diabetes distributed in five time-periods (2001-2003; 2004-2006; 2007-2009; 2010-2012 and 2013-2015), using Spanish national hospital discharge data. We estimated admission rates by diabetes status. We analyzed comorbidity, therapeutic procedures, and outcomes. We built Poisson regression models to compare the adjusted time-trends in admission rates. Type 2 diabetes cases were matched with controls using propensity score matching (PSM). We tested in-hospital mortality (IHM) in logistic regression analyses. We identified 16,626 hospitalizations in patients aged ≥ 40 years for IE in Spain, 2001-2015. The incidence of IE increased significantly from 6.0/100,000 per year to 13.1/100,000 per year (p < 0.001) in the population with type 2 diabetes, and from 3.9/100,000 per year to 5.5/100,000 per year (p < 0.001) in the population without diabetes, over the study period. The adjusted incidence of IE was 2.2-times higher among patients with diabetes than among those without diabetes (IRR = 2.2; 95% CI 2.1-2.3). People with type 2 diabetes less often underwent heart valve surgery than people without diabetes (13.9% vs. 17.3%; p < 0.001). Although IHM decreased significantly in both groups over time, it represented 20.8% of IE cases among diabetes patients and 19.9% among PSM matched controls (p = 0.337). Type 2 diabetes was not associated with a higher IHM in people admitted to the hospital for IE (OR = 1.1; 95% CI 0.9-1.2). Incidence rates of IE in Spain, among those with and without T2DM, have increased during the period 2001-2015 with significantly higher incidence rates in the T2DM population. In our population based study and after PSM we found that T2DM was not a predictor of IHM in IE.
Sections du résumé
BACKGROUND
The main aims of this study were to describe trends and outcomes during admission for infective endocarditis (IE) in people ≥ 40 years old with or without type 2 diabetes distributed in five time-periods (2001-2003; 2004-2006; 2007-2009; 2010-2012 and 2013-2015), using Spanish national hospital discharge data.
METHODS
We estimated admission rates by diabetes status. We analyzed comorbidity, therapeutic procedures, and outcomes. We built Poisson regression models to compare the adjusted time-trends in admission rates. Type 2 diabetes cases were matched with controls using propensity score matching (PSM). We tested in-hospital mortality (IHM) in logistic regression analyses.
RESULTS
We identified 16,626 hospitalizations in patients aged ≥ 40 years for IE in Spain, 2001-2015. The incidence of IE increased significantly from 6.0/100,000 per year to 13.1/100,000 per year (p < 0.001) in the population with type 2 diabetes, and from 3.9/100,000 per year to 5.5/100,000 per year (p < 0.001) in the population without diabetes, over the study period. The adjusted incidence of IE was 2.2-times higher among patients with diabetes than among those without diabetes (IRR = 2.2; 95% CI 2.1-2.3). People with type 2 diabetes less often underwent heart valve surgery than people without diabetes (13.9% vs. 17.3%; p < 0.001). Although IHM decreased significantly in both groups over time, it represented 20.8% of IE cases among diabetes patients and 19.9% among PSM matched controls (p = 0.337). Type 2 diabetes was not associated with a higher IHM in people admitted to the hospital for IE (OR = 1.1; 95% CI 0.9-1.2).
CONCLUSION
Incidence rates of IE in Spain, among those with and without T2DM, have increased during the period 2001-2015 with significantly higher incidence rates in the T2DM population. In our population based study and after PSM we found that T2DM was not a predictor of IHM in IE.
Identifiants
pubmed: 31752887
doi: 10.1186/s12933-019-0968-0
pii: 10.1186/s12933-019-0968-0
pmc: PMC6868776
doi:
Types de publication
Comparative Study
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
161Références
Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
J Heart Valve Dis. 2010 May;19(3):312-20
pubmed: 20583393
Med Clin (Barc). 2017 Mar 22;148(6):250-256
pubmed: 28081903
Int J Infect Dis. 2018 Mar;68:102-107
pubmed: 29382606
BMJ Open. 2016 Oct 5;6(10):e012463
pubmed: 27707830
Cir Esp. 2016 Mar;94(3):165-74
pubmed: 25841880
J Heart Valve Dis. 2005 Jan;14(1):23-8
pubmed: 15700431
Scand J Infect Dis. 2006;38(8):613-9
pubmed: 16857604
Scand J Infect Dis. 2004;36(11-12):795-8
pubmed: 15764163
Lancet. 2015 Mar 28;385(9974):1219-28
pubmed: 25467569
Rev Esp Cardiol. 2008 Aug;61(8):843-52
pubmed: 18684367
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
Scand J Infect Dis. 2007;39(2):101-7
pubmed: 17366025
Crit Care. 2019 Apr 25;23(1):143
pubmed: 31027489
Diabet Med. 2018 Nov;35(11):1499-1507
pubmed: 29908070
J Diabetes Complications. 2007 Nov-Dec;21(6):403-6
pubmed: 17967715
J Am Coll Cardiol. 2017 Dec 5;70(22):2795-2804
pubmed: 29191329
BMC Infect Dis. 2011 Feb 23;11:48
pubmed: 21345185
Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):336-45
pubmed: 26678152
Diabetes Care. 2018 Oct;41(10):2127-2135
pubmed: 30104296
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Am Coll Cardiol. 2012 May 29;59(22):1968-76
pubmed: 22624837
PLoS One. 2013 Dec 09;8(12):e82665
pubmed: 24349331
Diabetologia. 2012 Jan;55(1):88-93
pubmed: 21987347
J Clin Epidemiol. 2007 Apr;60(4):397-409
pubmed: 17346615
Eur Heart J. 2010 Aug;31(15):1890-7
pubmed: 20453066
Curr Vasc Pharmacol. 2012 Jan;10(1):19-32
pubmed: 22112354
Arch Intern Med. 2009 Mar 9;169(5):463-73
pubmed: 19273776
Infection. 2012 Oct;40(5):527-35
pubmed: 22711599
Rev Endocr Metab Disord. 2013 Mar;14(1):39-48
pubmed: 23417760
J Am Heart Assoc. 2019 May 7;8(9):e011598
pubmed: 31020901
N Engl J Med. 2019 Jan 31;380(5):415-424
pubmed: 30152252
Circulation. 2000 Dec 5;102(23):2842-8
pubmed: 11104742
Scand Cardiovasc J. 2018 Apr;52(2):58-68
pubmed: 29382232
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Interact Cardiovasc Thorac Surg. 2018 Oct 1;27(4):498-504
pubmed: 29659844
JAMA. 2017 Apr 25;317(16):1652-1660
pubmed: 28444279
Diabet Med. 1997 Jan;14(1):29-34
pubmed: 9017350
J Am Coll Cardiol. 2013 Dec 10;62(23):2217-26
pubmed: 23994421
N Engl J Med. 1999 Dec 16;341(25):1906-12
pubmed: 10601511
BMJ Open. 2016 Aug 05;6(8):e009952
pubmed: 27496226
Eur Heart J. 2007 Jan;28(1):59-64
pubmed: 17040927
Int J Cardiol. 2019 Mar 1;278:280-284
pubmed: 30291010
Int J Environ Res Public Health. 2019 Jun 25;16(12):
pubmed: 31242695
Circulation. 2004 Apr 13;109(14):1745-9
pubmed: 15037538
BMJ Open. 2019 Apr 20;9(4):e026811
pubmed: 31005935
Medicine (Baltimore). 2014 Mar;93(2):114-9
pubmed: 24646468
Am J Cardiol. 2010 Jul 1;106(1):92-8
pubmed: 20609654